A bold vision and a transformative approach, driven by our deep expertise.
Our Management, Board of Directors, and Scientific Advisory Board are comprised of world-class GI and autoimmune experts. Most with the experience and knowledge gained at large pharmaceutical companies and adapted to our unique culture of innovation and agility. All united by their desire to improve the treatment paradigm by developing targeted therapies.
Breakthrough ideas start at the top
Our Board brings a wealth of experience that adds up to clear direction—and a strong sense of purpose.
Board of Directors
Mark C. McKenna
Helen C. Adams
Martin Hendrix, Ph.D.
Joseph C. Papa
Judith L. Swain, M.D.